Semaglutide is a GLP-1 receptor agonist that mimics the incretin hormone GLP-1 to increase insulin secretion, slow gastric emptying, and suppress appetite. It is prescribed for type 2 diabetes management, chronic weight loss, and lowering the risk of major cardiovascular events.